Publication list of Makoto Nakamura as of July 7, 2021 (Only written in English)

I. Original Articles
1. Nakamura M, Ara F, Yamada M, Hotta Y, Hayakawa M, Fujiki K, Kanai A, Sakai J, Inoue M,
Yamamoto M, Fujiwara Y, Umoto A, Miyazaki S, Shimo-oku M, Furuyama J, Nakajima A, Imachi
J. High frequency of mitochondrial ND4 gene mutation in Japanese pedigrees with Leber
hereditary optic neuropathy. Jpn J Ophthalmol 1992, 36: 56-61. (IF=0.924, CI=24)
2. Nakamura M, Fujiwara Y, Yamamoto M. Homoplasmic and exclusive ND4 gene mutation in
Japanese pedigrees with Leber's disease. Invest Ophthalmol Vis Sci 1993, 34: 488-495. (IF=3.597,
CI=12)
3. Nakamura M, Fujiwara Y, Yamamoto M. The two locus control of Leber hereditary optic
neuropathy and a high penetrance in Japanese pedigrees. Hum Genet 1993, 91: 339-341.
(IF=5.069, CI=29)
4. Fujiwara Y, Nakamura M, Yokoo S. A new anticancer platinum compound, (-)-(R)-2aminomethlpyrrolidine (1,1-cyclobutanedicarboxylato) platinum (Ⅱ): DNA interstrand
crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma
pigmentosum cells. Br J Cancer 1993, 67:1285-1292. (IF=5.042, CI=10)
5. Nakamura M. Genetic analysis of Japanese pedigrees with Leber's hereditary optic neuropathy.
Kobe Journal of Medical Sciences 1993, 39:171-182. (IF=0, CI=0)
6. Nakamura M, Yamamoto M. DNA interstrand crosslinking agents and human ocular fibroblasts:
Differential sensitivity to Mitomycin-C and cis-Diaminedichloroplatinum (II). Exp Eye Res
1994, 59:53-62. (IF=3.259, CI=7)
7. Hotta Y, Fujiki Y, Hayakawa M, Nakajima A, Kanai A, Mashima Y, Hiida Y, Shinoda K, Yamada
K, Oguchi Y, Ishida M, Yanashima K, Wakakura M, Ishikawa S, Nakamura M, Sakai J,
Yamamoto M, Hayashi T, Mitani I, Miyazaki S, Shimo-oku M, Imachi J, Kuniyoshi N, Nagataki
S, Isashiki Y, Ohba N. Clinical features of Japanese Leber's hereditary optic neuropathy with
11778 mutation of mitochondrial DNA. Jpn J Ophthalmol 1995, 39: 96-108. (IF= 0.924, CI=33)
8. Nakamura M, Sekiya Y, Yamamoto M. Preservation of photic blink reflex in Leber's hereditary
optic neuropathy. Invest Ophthalmol Vis Sci 1996, 37: 2736-2743. (IF=3.597, CI=6)
9. Nakamura M, Sekiya Y, Yamamoto M. Evaluation of bilateral undefined optic neuropathy basedon mitochondrial genetics. Neuro-ophthalmology 1996, 16: 91-97. (IF=0.256, CI=2)
10. Yamamoto M, Dogru M, Nakamura M, Shirabe H, Tsukahara Y, Sekiya Y. Visual function
following congenital cataract surgery. Jpn J Ophthalmol 1998, 42: 411-416. (IF=0.924, CI=13)
11. Dogru M, Inoue M, Nakamura M, Yamamoto M. Modifying factors related to asymmetricdiabetic retinopathy. Eye 1998, 12: 929-933. (IF=1.851, CI=14)

12. Shirabe H, Suda K, Mori Y, Dogru M, Nakamura M, Sekiya Y, Yamamoto M. Visual function
following unilateral congenital cataract surgery. American Orthoptic Journal 1998, 48: 97-103.
(IF=0, CI=0)
13. Yamada K, Oguchi Y, Hotta Y, Nakamura M, Isashiki Y, Mashima Y. Multicenter study on thefrequency of three primary mutations of mitochondrial DNA in Japanese pedigrees with Leber's
hereditary optic neuropathy: Comparison with American and British counterparts.
Neuro-ophthalmology 1999, 22: 187-193. (IF=0.256, CI=9)
14. Dogru M, Nakamura M, Inoue M, Yamamoto M. Long-term visual outcome in proliferative
diabetic retinopathy patients after panretinal photocoagulation. Jpn J Ophthalmol 1999, 43:
217-224. (IF=0.924, CI=8)
15. Maeda H, Tanaka Y，Nakamura M, Yamamoto M. Blue-on-Yellow perimetry using an Armaly
glaucoma screening program. Ophthalmologica 1999, 213: 71-75. (IF=1.424, CI=7)
16. Maeda H, Nakamura M, Yamamoto M. Morphometric features of laminar pores in lamina
cribrosa observed by scanning laser ophthalmoscopy. Jpn J Ophthalmol 1999, 43: 415-421.
(IF=0.924, CI=8)
17. Dogru M, Shirabe H, Nakamura M, Sekiya Y, Matsuo M, Taoka K, Nomura K, Yamamoto M.
Development of grating acuity in infants with retinopathy of prematurity. Acta Ophthalmol
Scand 1999, 77:72-75. (IF=1.848, CI=4)
18. Nakamura M, Hara R, Kimura R, Ohgiya N, Yamamoto N, Morino I, Yamamoto M. Optic
perineuritis not associated with syphilitic infection. Neuro-ophthalmology 1999, 21: 135-145.
(IF=0.256, CI=2)
19. Maeda H, Eno A, Nakamura M, Negi A. Safe management of a late-onset bleb leak with aneedling technique. Eye 2000, 14: 802-804. (IF=1.851, CI=6)
20. Maeda H, Nakamura M, Negi A. New perimetric threshold test algorithm with dynamic strategy
and tendency oriented perimetry (TOP) in glaucomatous eyes. Eye 2000, 14: 747-751.
(IF=1.851, CI=7)
21. Nakamura M, Yamamoto M. Variable pattern of visual recovery of Leber's hereditary optic
neuropathy. Br J Ophthalmol 2000, 84: 534-535. (IF=2.902, CI=16)
22. Dogru M, Shirabe H, Nakamura M, Taoka K, Nomura K, Yamamoto M. Effect of retinopathy ofprematurity on resolution acuity development in 1-to 3-year-old children. J Pediatric
Ophthalmol Strabismus 2001, 38: 144-148. (IF=0.626, CI=0)
23. Maeda H, Nakamura M, Negi A. Selective reduction of the S-cone component of theelectroretinogram in Posner-Schlossman syndrome. Eye 2001, 15:163-167. (IF=1.851, CI=1)
24. Barber AJ, Nakamura M (equal contributor), Wolpert EB, Reiter CEN, Seigel GM, Antonetti
DA, Gardner TW. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol

3-kinase/akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 2001,
276: 32814-32821. (IF=4.773, CI=154)
25. Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, Buse MG, Gardner TW.
Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in
retinal neurons. J Biol Chem 2001, 276: 43748-43755. (IF=4.773, CI=73)
26. Kanamori A, Escano MT, Eno A, Nakamura M, Maeda H, Seya R, Ishibashi K, Negi A.
Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optic
coherence tomography. Ophthalmologica 2003, 217: 273-278. (IF=1.424, CI=55)
27. Kanamori A, Nakamura M, Escano MFT, Seya R, Maeda H, Negi A. Evaluation of theglaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence
tomography. Am J Ophthalmol 2003, 135:513-520. (IF=4.223, CI=146)
28. Kanamori A, Nakamura M (corresponding author), Mukuno H, Maeda H, Negi A. Diabetes
has an additive effect on neural apoptosis in rat retina with chronically elevated intraocularpressure. Curr Eye Res 2004, 28: 47-54. (IF=1.28, CI=35)
29. Kanamori A, Matsui N, Tatsumi Y, Nagai A, Nakanishi Y, Nakamura M, Negi A. Opticalcoherence tomography detects characteristic retinal nerve fiber layer thickness corresponding toband atrophy of the optic discs. Ophthalmology 2004, 111: 2278-2283. (IF=5.454, CI=38)
30. Kanamori A, Nakamura M (corresponding author), Nakanishi Y, Nagai A, Mukuno H, Yamada
Y, Negi A. Akt is activated via insulin / IGF-1 receptor in rat retina with episcleral veincauterization. Brain Res 2004, 1022: 195-204. (IF=2.728, CI=19)
31. Mukuno H, Nakamura M (corresponding author), Nagai A, Kanamori A, Negi A. Unoprostone
isopropyl rescues retinal progenitor cells from apoptosis in vitro. Curr Eye Res 2004, 29:457-464. (IF=1.28, CI=13)
32. Kanamori A, Nagai-Kusuhara A, Escano MF, Maeda H, Nakamura M, Negi A. Comparison ofconfocal scanning laser ophthalmoscopy, scanning laser polarimetry and optical coherence
tomography to discriminate ocular hypertension and glaucoma at an early stage. Graefes Arch
Clin Exp Ophthalmol 2005, 26: 1-11. (IF=2.17, CI=46)
33. Kanamori A, Nakamura M (corresponding author), Nakanishi Y, Yamada Y, Negi A.
Long-term glial reactivity in rat retinas ipsilateral and contralateral to experimental glaucoma.
Exp Eye Res 2005, 81: 48-56. (IF=3.259, CI=26)
34. Reiter CE, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RS, Fort PE, Antonetti
DA, Gardner TW. Diabetes reduces basal retinal insulin receptor signaling: reversal withsystemic and local insulin. Diabetes 2006, 55: 1148-1156. (IF=8.286, CI=48)
35. Nakanishi Y, Nakamura M (corresponding author), Tatsumi Y, Nagai-Kusuhara A, Negi A.
Quantification of retinal nerve fiber thickness reduction associated with a relative afferent
pupillary defect. Graefes Arch Clin Exp Ophthalmol 2006, 244:1480-1484. (IF=2.17 CI=4)

36. Kusuhara S, Nakamura M, Nagai-Kusuhara A, Nakanishi Y, Kanamori A, Negi A. Macular
thickness reduction in eyes with unilateral optic atrophy detected with optical coherence
tomography. Eye 2006, 20: 882-887. (IF=1.851, CI=6)
37. Nakanishi Y, Nakamura M (corresponding author), Mukuno H, Kanamori A, Seigel GM, Negi
A. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which ismediated by p44/p42 mitogen-activated protein kinase. Exp Eye Res 2006, 83:1108-1117.
(IF=3.259, CI=19)
38. Nakamura M, Darhad U, Tatsumi Y, Fujioka M, Kusuhara A, Maeda H, Negi A. Agreement ofrebound tonometer in measuring intraocular pressure with three types of applanation tonometers.
Am J Ophthalmol 2006, 142: 332-334. (IF=4.223, CI=32)
39. Nagai-Kusuhara A, Nakamura M (corresponding author), Mukuno H, Kanamori A, Negi A,
Seigel GM. cAMP-responsive element binding protein mediates a cGMP/protein kinase
G-dependent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells.
Exp Eye Res. 2007, 84: 152-162. (IF=3.259, CI=13)
40. Fujioka M, Nakamura M (corresponding author), Tatsumi Y, Kusuhara A, Maeda H, Negi A.
Comparison of Pentacam Scheimpflug camera with ultrasound pachymetry and noncontact
specular microscopy in measuring central corneal thickness. Curr Eye Res 2007, 32: 89-94.
(IF=1.28, CI=21)
41. Tatsumi Y, Nakamura M (corresponding author), Fujioka M, Nakanishi Y, Kusuhara A, Maeda
H, Negi A. Quantification of retinal nerve fiber layer thickness reduction associated with arelative afferent pupillary defect in asymmetric glaucoma. Br J Ophthalmol 2007, 91: 633-637.
(IF=2.902, CI=7)
42. Nagai-Kusuhara A, Nakamura M (corresponding author), Kanamori A, Nakanishi Y, Kusuhara
S, Negi A. Evaluation of optic nerve head configuration in various types of optic neuropathy
with Heidelberg Retina Tomograph. Eye. 2008, 22: 1154-1160. (IF=1.851, CI=7)
43. Nagai-Kusuhara A, Nakamura M (corresponding author), Fujioka M, Tatsumi Y, Negi A.
Association of retinal nerve fiber layer thickness measured by confocal scanning laser
ophthalmoscopy and optical coherence tomography with disc size and axial length. Br J
Ophthalmol 2008, 92: 186-190. (IF=2.902, CI=26)
44. Nagai-Kusuhara A, Nakamura M (corresponding author), Fujioka M, Negi A. Long-term
results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes
Arch Clin Exp Ophthalmol. 2008, 246: 567-571. (IF=2.17, CI=6)
45. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H, Kawase K, Yamamoto T,
Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H, Aihara M, Araie M, Fukuchi
T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase A, Ohno S, Inoko H, Mizuki

N. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma.
Invest Ophthalmol Vis Sci. 2008, 49: 4453-4457. (IF=3.597, CI=25
46. Nagai-Kusuhara A, Nakamura M (corresponding author), Tatsumi Y, Nakanishi Y, Negi A.
Disagreement between Heidelberg Retina Tomograph and optical coherence tomography inassessing optic nerve head configuration of eyes with band atrophy and normal eyes. Br J
Ophthalmol. 2008, 92: 1382-1386. (IF=2.902, CI=8)
47. Tatsumi Y, Kanamori A, Nagai-Kusuhara A, Nakanishi Y, Agarwal N, Negi A, Nakamura M(corresponding author). Nipradilol protects rat retinal ganglion cells from apoptosis induced
by serum deprivation in vitro and by diabetes in vivo. Curr Eye Res. 2008, 33: 683-692.
(IF=1.28, CI=2)
48. Akiyama M, Yatsu K, Ota M, Katsuyama Y, Kashiwagi K, Mabuchi F, Iijima H, Kawase K,
Yamamoto T, Nakamura M, Negi A, Sagara T, Kumagai N, Nishida T, Inatani M, Tanihara H,
Ohno S, Inoko H, Mizuki N. Microsatellite analysis of the GLC1B locus on chromosome 2
points to NCK2 as a new candidate gene for normal tension glaucoma. Br J Ophthalmol. 2008,
92: 1293-1296. (IF=2.902, CI=4)
49. Darhad U, Nakamura M (corresponding author), Fujioka M, Tatsumi Y, Nagai-Kusuhara A,
Maeda H, Negi A. Intraocular pressure lowering effect of once daily versus once weekly
latanoprost instillation in the same normal individuals. Kobe J Med Sci. 2008, 53:297-304.
(IF=0, CI=0)
50. Kanamori A, Naka M, Nagai-Kusuhara A, Yamada Y, Nakamura M, Negi A. Regional
relationship between retinal nerve fiber layer thickness and corresponding visual field sensitivity
in glaucomatous eyes. Arch Ophthalmol. 2008, 126: 1500-1506. (IF=3.711, CI=14)
51. Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R, Miyazaki M, Hisatomi
T, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K. Inhibition of nuclear translocationof apoptosis-inducing factor is an essential mechanism of the neuroprotective activity ofpigment epithelium-derived factor in a rat model of retinal degeneration. Am J Pathol 2008, 173:1326-1338. (IF=4.89, CI=30)
52. Nakamura M, Kanamori A, Nagai-Kusuhara A, Kusuhara S, Yamada Y, Negi A. Serous maculardetachment due to diabetic papillopathy detected using optical coherence tomography. Arch
Ophthalmol 2009, 127: 105-107. (IF=3.711, CI=0)
53. Nagai-Kusuhara A, Nakamura M (corresponding author), Kanamori A, Negi A. Association of
optic disc configuration and clustered visual field sensitivity in glaucomatous eyes withhemifield visual field defects. J Glaucoma 2009, 18: 62-68. (IF=1.776, CI=2)
54. Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A. Latanoprost protects rat retinal
ganglion cells from apoptosis in vitro and in vivo. Exp Eye Res. 2009, 88: 535-541. (IF=3.259,
CI=9)

55. Arimura N, Ki-I Y, Hashiguchi T, Kawahara K, Biswas KK, Nakamura M, Sonoda Y, Yamakiri
K, Okubo A, Sakamoto T, Maruyama I. Intraocular expression and release of high-mobility
group box 1 protein in retinal detachment. Lab Invest 2009, 89: 278-289. (IF=3.641, CI=17)
56. Nakamura J, Meguro A, Ota M, Nomura E, Nishide T, Kashiwagi K, Mabuchi F, Iijima H,
Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H,
Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase
A, Ohno S, Inoko H, Mizuki N. Association of toll-like receptor 2 gene polymorphisms withnormal tension glaucoma. Mol Vis 2009, 15: 2905-2910. (IF=2.205, CI=2)
57. Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A. Tafluprost protects rat retinal ganglion
cells from apoptosis in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol. 2009, 247:
1353-1360. (IF=2.17, CI=6)
58. Nakamura K, Ota M, Meguro A, Nomura N, Kashiwagi K, Mabuchi F, Iijima H, Kawase K,
Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H, Aihara M,
Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase A, Ohno S,
Inoko H, Mizuki N. Association of microsatellite polymorphisms of the GPDS1 locus withnormal tension glaucoma in the Japanese population. Clin Ophthalmol 2009, 3: 307-312. (IF=0,
CI=0)59. Kamino M, Meguro A, Nomura N, Kashiwagi K, Mabuchi F, Iijima H, Kawase K, Yamamoto T,
Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H, Aihara M, Araie M, Fukuchi
T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase A, Ohno S, Inoko H, Mizuki
N. Investigation of the association between the GLC3A locus and normal tension glaucoma inJapanese patients with microsatellite analysis. Clin Ophthalmol 2009, 3: 183-188. (IF=0, CI=0)60. Naka M, Kanamori A, Tatsumi Y, Fujioka M, Nagai-Kusuhara A, Nakamura M, Negi A.
Comparison of mean deviation with AGIS and CIGTS scores in association with structuralparameters in glaucomatous eyes. J Glaucoma 2009, 18: 379-384. (IF=1.776, CI=1)
61. Suzuki M, Meguro A, Ota M, Nomura E, Kato T, Nomura N, Kashiwagi K, Mabuchi F, Iijima
H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H,
Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi.
Genotyping HLA-DRB1 and HLA-DQB1 alleles in Japanese patients with normal tension
glaucoma. Mol Vis 2010, 16: 1874-1879. (IF=2.205, CI=0)62. The writing committee for the normal tension glaucoma genetic study group of Japan Glaucoma
Society. Genome-wide association study of normal tension glaucoma: Common variants in
SRBD1 and ELOLV5 contribute to disease susceptibility. Ophthalmology 2010, 117: 1331-1338.
(IF=5.454, CI=20)
63. Murakami K, Meguro A, Ota M, Shiota T, Nomura N, Kashiwagi K, Mabuchi F, Iijima H,
Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H,

Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase
A, Ohno S, Inoko H, Mizuki N. Analysis of microsatellite polymorphisms within the GLC1F
locus in Japanese patients with normal tension glaucoma. Mol Vis 2010, 16: 462-466. (IF=2.205,
CI=0)64. Fukuda M, Nakanishi Y, Fuse M, Yokoi N, Hamada Y, Fukagawa M, Negi A, Nakamura M(corresponding author). Altered expression of aquaporins 1 and 4 coincides withneurodegenerative events in retinas of spontaneously diabetic Torii rats. Exp Eye Res 2010, 90:
17-25. (IF=3.259, CI=5)
65. Naka M, Kanamori A, Negi A, Nakamura M (corresponding author). Reduced expression ofaquaporin-9 in rat optic nerve head and retina following elevated intraocular pressure. Invest
Ophthalmol Vis Sci 2010, 51: 4618-4626. (IF=3.597, CI=7)
66. Otsuka H, Arimura N, Sonoda S, Nakamura M, Hashiguchi T, Maruyama I, Nakao S,
Hafezi-Moghadam A, Sakamoto T. Stromal cell-derived factor 1 is essential for photoreceptor
cell protection in retinal detachment. Am J Pathol 2010, 177: 2268-2277. (IF=4.89, CI=7)
67. Ishikawa K, Nagai T, Yamada Y, Negi A, Nakamura M (corresponding author). Optimal
conditions for multifocal VEP recording for normal Japanese population established by receiver
operating characteristic analysis. Doc Ophthalmol 2011, 122: 29-37. (IF=2.107, CI=2)
68. Fukuda M, Naka M, Mizokami J, Negi A, Nakamura M (corresponding author). Diabetes
induces expression of aquaporin-0 in the retinal nerve fibers of spontaneously diabetic Torii rats.
Exp Eye Res 2011, 91: 195-201 (IF=3.259, CI=1).
69. Yamamoto T, Kuwayama Y, The Collaborative Bleb-related Infection Incidence and Treatment
Study Group. Interim clinical outcomes in the collaborative bleb-related infection incidence andtreatment study. Ophthalmology 2011, 118: 453-458. (IF=5.454, CI=5)
70. Yasumura R, Meguro A, Ota M, Nomura E, Uemoto R, Kashiwagi K, Mabuchi F, Iijima H,
Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H,
Aihara M Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase
A, Ohno S, Inoko H, Mizuki N. Investigation of the association between SLC1A3 gene
polymorphisms and normal tension glaucoma. Mol Vis 2011, 17: 792-796. (IF=2.205, CI=1)
71. Mizokami J, Yamada Y, Negi A, Nakamura M (corresponding author). Postural changes inintraocular pressure are associated with asymmetrical retinal nerve fiber thinning in treatedpatients with primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol, 2011,
249:879-885. (IF=2.17, CI=3)
72. Fort PE, Losiewicz MK, Reiter CEN, Singh RSJ, Nakamura M, Abcouwer SF, Barber AJ,
Gardner TW. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced
retinal cell death: Evidence for retinal insulin resistance. PloS One 2011, 6: e26498. (IF=4.092,
CI=1)

73. Nakamura M, Ishikawa K, Nagai T, Negi A. Receiver-operating characteristic analysis ofmultifocal VEPs to diagnose and quantify glaucomatous functional damage. Doc Ophthalmol
2011, 123: 93-108. (IF=2.107, CI=0)74. Mizokami J, Kanamori A, Negi A, Nakamura M (corresponding author). A preliminary studyof reduced expression of aquaporin-9 in the optic nerve of primate and human eyes withglaucoma. Curr Eye Res 2011, 36: 1064-1067. (IF=1.28, CI=1)
75. Nakamura M, Naka M, Tatsumi Y, Nagai-Kusuhara A, Kanamori A, Yamada Y, Negi A. Filtering
bleb structure associated with long-term intraocular pressure control after amniotic
membrane-assisted trabeculectomy. Curr Eye Res 2012, 37: 239-250. (IF=1.28, CI=0)
76. Kanamori A, Nakamura M, Tabuchi K, Yamada Y, Negi A. Effects of ocular rotation onparapapillary retinal nerve fiber layer thickness analysis measured with spectral-domain opticalcoherence tomography. Jpn J Ophthalmol. 2012, 56:354-361. (IF=0.924, CI=1)
77. Kanamori A, Nakamura M, Tomioka M, Kawaka Y, Yamada Y, Negi A. Agreement among three
types of spectral-domain optical coherent tomography instruments in measuring parapapillary
retinal nerve fibre layer thickness. Br J Ophthalmol 2012, 96: 832-837. (IF=2.902, CI=1)
78. Kanamori A, Nakamura M, Yamada Y, Negi A. Longitudinal study of retinal nerve fiber layer
thickness and ganglion cell complex in traumatic optic neuropathy. Arch Ophthalmol. 2012,
130:1067-1069. (IF=3.711, CI=0)
79. Nakamura M, Ishikawa-Tabuchi K, Kanamori A, Yamada Y, Negi A. Better performance of
RTVue than Cirrus spectral-domain optical coherence tomography in detecting band atrophy ofthe optic nerve. Graefes Arch Clin Exp Ophthalmol. 2012, 250: 1499-1507. (IF=2.17, CI=0)80. Kanamori A, Nakamura M, Yamada Y, Negi A. Spectral-domain optical coherence tomography
detects optic atrophy due to optic tract syndrome. Graefes Arch Clin Exp Ophthalmol 2013, 251:591-595. (IF=2.17, CI=0)81. Otsuka H, Kawano H, Sonoda S, Nakamura M, Sakamto T: Particle-induced endophthalmitis:
Possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Invest
Ophthalmol Vis Sci 2013; 54: 1758-1766. (IF=3.597, CI=3)
82. Miki A, Kanamori A, Negi A, Naka M, Nakamura M (corresponding author). The loss ofaquaporin 9 expression adversely affects the survival of retinal ganglion cells. Am J Pathol 2013,
182: 1727-1739 (IF=4.89, CI=0)83. Sakamoto M, Kanamori A, Fujihara M, Yamada Y, Nakamura M, Negi A. Assessment of
IcareOne rebound tonometer for self-measuring intraocular pressure. Acta Ophthalmol 2013,
Epub ahead of print (IF=2.629, CI=0)
84. Kanamori A, Nakamura M, Tomioka M, Kawaka Y, Yamada Y, Negi A. Structure-function
relationship among three types of spectral-domain optical coherent tomography instruments inmeasuring parapapillary retinal nerve fiber layer thickness. Acta Ophthalmol 2013, 91: e196-202(IF=2.629, CI=0)
85. Akashi A, Kanamori A, Nakamura M, Fujihara M, Yamada Y, Negi A. Comparative assessment
for the ability of Cirrus, RTVue, and 3D-OCT to diagnose glaucoma. Invest Ophthalmol Vis Sci
2013; 54: 4478-4484. (IF=3.597, CI=0).
86. Kato T, Meguro A, Nomura E, Uemoto R, Nomura N, Ota M, Kashiwagi K, Mabuchi F, Iijima
H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida K, Inatani M, Tanihira H,
Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase
A, Chin S, Inoko H, Mizuki N. Association study of genetic variants on chromosome 7q31 withsusceptibility to normal tension glaucoma in a Japanese population. Eye 2013; 27: 979-983.
(IF=1.851, CI=0).
87. Akashi A, Kanamori A, Nakamura M, Fujihara M, Yamada Y, Negi A. The ability of macularparameters and circumpapillary retinal nerve fiber layer by three SD-OCT instruments todiagnose highly myopic glaucoma. Invest Ophthalmol Vis Sci 2013, 54(9):6025-32. (IF=3.597,
CI=0).
88. Kanamori A, Naka M, Akashi A, Fujihara M, Yamada Y, Nakamura M. Cluster analyses ofgrid-pattern display in macular parameters using optical coherence tomography for glaucoma
diagnosis. Invest Ophthalmol Vis Sci. 2013, 54(9):6401-8.
89. Matsumoto Y, Kanamori A, Nakamura M, Takahashi T, Nakashima I, Negi A. Sera frompatients with seropositive neuromyelitis optica spectral disorders caused the degeneration ofrodent optic nerve. Exp Eye Res. 2014,119:61-9.
90. Yamamoto T, Sawada A, Mayama C, Araie M, Ohkubo S, Sugiyama K, Kuwayama
Y;Collaborative Bleb-Related Infection Incidence and Treatment Study Group. The 5-year
incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive
mitomycin C: collaborative bleb-related infectionincidence and treatment study 2.
Ophthalmology. 2014,121(5):1001-6.
91. Matsumoto Y, Fujihara M, Kanamori A, Yamada Y, Nakamura M (corresponding author).
Effect of axial length reduction after trabeculectomy on the development of hypotony
maculopathy. Jpn J Ophthalmol. 2014, 58(3):267-75.
92. Matsumoto Y, Kanamori A, Nakamura M, Negi A. Rat chronic glaucoma model induced byintracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate. Jpn J
Ophthalmol. 2014 May, (3):290-7.
93. Kawano H, Ito T, Yamada S, Hashiguchi T, Maruyama I, Hisatomi T, Nakamura M, Sakamoto
T. Toxic effects of extracellular histones and their neutralization by vitreous in retinal
detachment. Lab Invest. 2014, 94(5):569-85.

94. Nakamura M, Kato K, Kamata S, Ishikawa K, Nagai T. Effect of refractive errors on multifocal
VEP responses and standard automated perimetry tests in a single population. Doc Ophthalmol.
2014, 128(3):179-89.
95. Akashi A, Kanamori A, Ueda K, Matsumoto Y, Yamada Y, Nakamura M. The detection ofmacular analysis by SD-OCT for optic chiasmal compression neuropathy and nasotemporal
overlap. Invest Ophthalmol Vis Sci. 2014,55(7) :4667-72.
96. Sakamoto M, Kanamori A, Fujihara M, Yamada Y, Nakamura M, Negi A. Assessment of
IcareONE rebound tonometer for self-measuring intraocular pressure. Acta Ophthalmol.
2014;92:243-8
97. Miki A, Kanamori A, Nakamura M, Matsumoto Y, Mizokami J, Negi A. The expression ofsyntaphilin is down-regulated in the optic nerve after axonal injury. Exp Eye Res.
2014;129:38-47.
98. Hirose M, Matsumiya W, Honda S, Nakamura M. Efficacy and visual prognostic factors of
intravitreal bevacizumab as needed for macular edema secondary to central retinal vein
occlusion. Clin Ophthalmol. 2014;8:2301-5.
99. Akashi A, Kanamori A, Ueda K, Inoue Y, Yamada Y, Nakamura M.The Ability of SD-OCT
to Differentiate Early Glaucoma With High Myopia From Highly Myopic Controls andNonhighly Myopic Controls. Invest Ophthalmol Vis Sci. 2015;56: 6573-80.
100.

Ueda K, Kanamori A, Akashi A, Matsumoto Y, Yamada Y, Nakamura M. Evaluation of

the distribution pattern of the circumpapillary retinal nerve fibre layer from the nasal
hemiretina. Br J Ophthalmol.2015;99:1419-23.
101.

Inoue Y, Kato K, Kamata S, Ishikawa K, Nakamura M. Reproducibility in the global

indices for multifocal visual evoked potentials and Humphrey visual fields in controls andglaucomatous eyes within a 2-year period. Doc Ophthalmol.2015;131:115-24.
102.

Ueda K, Kanamori A, Akashi A, Kawaka Y, Yamada Y, Nakamura M. Difference incorrespondence between visual field defect and inner macular layer thickness measured
using three types of spectral-domain OCT instruments. Jpn J Ophthalmol. 2015;59:55-64
103.

Akashi A, Miki A, Kanamori A, Nakamura M. Aquaporin 9 expression is required for l-lactate to maintain retinal neuronal survival. Neurosci Lett. 2015;589:185-90.
104.

Matsumiya W, Honda S, Otsuka K, Miki A, Nagai T, Imai H, Kusuhara S, Nakamura M.

Comparison of the Effectiveness and Prognostic Factors of Intravitreal Ranibizumab
between Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal
Vasculopathy over 24 Months of Follow-Up. Ophthalmologica. 2015;234:33-9.
105.

Ueda K, Kanamori A, Akashi A, Tomioka M, Kawaka Y, Nakamura M. Effects of Axial

Length and Age on Circumpapillary Retinal Nerve Fiber Layer and Inner MacularParameters Measured by 3 Types of SD-OCT Instruments. J Glaucoma. 2016;25(4):383-9.
106.

Nishisako M , Meguro A, Nomura E, Yamane T, Takeuchi M, Ota M, Kashiwagi

K, Mabuchi F, Iijima H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida
T, Inatani M, Tanihara H, Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama
K, Kanamoto T, Kiuchi Y, Iwase A, Chin S, Ohno S, Inoko H, Mizuki N. SLC1A1 Gene

Variants and Normal Tension Glaucoma: An Association Study. Ophthalmic Genet.
2016;15:1-7.
107.

Nobuyoshi S, Kanamori A, Matsumoto Y, Nakamura M. Rescue effects of intravenous

immunoglobulin on optic nerve degeneration in a rat model of neuromyelitis optica. Jpn J
Ophthalmol. 2016 Sep;60(5):419-23
108.

Sakamoto M, Mori S, Ueda K, Akashi A, Inoue Y, Kurimoto T, Kanamori A, Yamada Y,

Nakamura M. Diagnostic utility of combined retinal ganglion cell count estimates inJapanese glaucoma patients. Jpn J Ophthalmol. 2018 ;62(1):31-40.
109.

Nakai S, Honda S, Matsumiya W, Miki A, Nakamura M. ARMS2 variants may predictthe 3-year outcome of photodynamic therapy for wet age-related macular degeneration. Mol
Vis. 2017 ;23:514-519. eCollection 2017.
110.

Ueda K, Morizane Y, Shiraga F, Shikishima K, Ishikawa H, Wakakura M, Nakamura M.

Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan. J
Epidemiol. 2017;27(9):447-450.
111.

Nakai S, Honda S, Miki A, Matsumiya W, Nakamura M. Comparison of the 12-monthoutcomes of intravitreal ranibizumab between two angiographic subtypes of polypoidal
choroidal vasculopathy. Ophthalmologica. 2017;237(3):123-127.
112.

Matsumoto Y, Mori S, Ueda K, Kurimoto T, Kanamori A, Yamada Y, Nakashima I,

Nakamura M. Impact of the anti-aquaporin-4 autoantibody on inner retinal structure,function and structure-function associations in Japanese patients with optic neuritis. PLoS
One. 2017 Feb 15;12(2):e0171880.
113.

Honda S, Miki A, Kusuhara S, Imai H, Nakamura M. Choroidal thickness of central

serous chorioretinopathy secondary to corticosteroid use. Retina. 2017;37(8):1562-1567.
114.

Matsumiya W, Honda S, Otsuka K, Miki A, Nagai T, Imai H, Kusuhara S, Nakamura M.

One-year outcome of combination therapy with intravitreal aflibercept and verteporfin
photodynamic therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp
Ophthalmol. 2017;255(3):541-548.
115.

Sakamoto M, Mori S, Ueda K, Akashi A, Inoue Y, Kurimoto T, Kanamori A, Yamada Y,

Nakamura M. Diagnostic utility of combined retinal ganglion cell count estimates inJapanese glaucoma patients. Jpn J Ophthalmol. 2018 ;62(1):31-40.
116.

Ueda K, Onishi A, Ito SI, Nakamura M, Takahashi M. Generation of three-dimensional

retinal organoids expressing rhodopsin and S- and M-cone opsins from mouse stem cells.
Biochem Biophys Res Commun. 2018;495(4):2595-2601.
117.

Sakamoto M, Matsumoto Y, Mori S, Ueda K, Inoue Y, Kurimoto T, Kanamori A,

Yamada Y, Nakamura M. Excessive scleral shrinkage, rather than choroidal thickening, is amajor contributor to the development of hypotony maculopathy after trabeculectomy. PLoS
One. 2018;13(1):e0191862..
118.

(Shiga Y), Nakamura M, et al. Genome-wide association study identifies seven novel

susceptibility loci for primary open-angle glaucoma. Hum Mol Genet. 2018;27(8):14861496.

119.

Kusuhara S, Katsuyama A, Matsumiya W, Nakamura M. Efficacy and safety of ripasudil,

a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma. Graefes Arch Clin Exp
Ophthalmol. 2018;256(4):809-814.
120.

Mori S, Kurimoto T, Ueda K, Nakamura M. Short-term effect of additional apheresis on

visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica
spectrum disorders. Jpn J Ophthalmol. 2018;62(4):525-530.
121.

(Hosoda Y), Honda S, Miki A, Nakamura M; Nagahama Study Group. CFH and VIPR2

as susceptibility loci in choroidal thickness and pachychoroid disease central serous
chorioretinopathy. Proc Natl Acad Sci U S A. 2018;115(24):6261-6266.
122.

Mori S, Sakamoto M, Kurimoto T, Kanamori A, Ueda K, Inoue Y, Yamada Y, Nakamura

M. Effectiveness and safety of sulcus fixation of Baerveldt glaucoma implants inglaucomatous eyes in patients who underwent multiple intraocular surgeries. Graefes Arch
Clin Exp Ophthalmol. 2018. 256(10):1953-1960
123.

Sakamoto M, Mori S, Ueda K, Kurimoto T, Kusuhara S, Yamada-Nakanishi Y,

Nakamura M. En Face Slab Images Visualize Nerve Fibers With Residual Visual Sensitivity
in Significantly Thinned Macular Areas of Advanced Glaucomatous Eyes.Invest
Ophthalmol Vis Sci. 2019;60(8):2811-2821.
124.

Kurimoto T, Ueda K, Mori S, Sakamoto M, Yamada-Nakanishi Y, Matsumiya W,

Nakamura M. A study protocol for evaluating the efficacy and safety of skin electricalstimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomized
prospective exploratory study. Clin Ophthalmol. 2019;13:897-904.
125.

Ishikawa H, Kezuka T, Shikishima K, Yamagami A, Hiraoka M, Chuman H, Nakamura

M, Hoshi K, Goseki T, Mashimo K, Mimura O, Yoshitomi T, Tanaka K; Working Group on
Diagnostic Criteria for Refractory Optic Neuritis Based on Neuroimmunological Perspective.
Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan. Ophthalmology. 2019
126(10):1385-1398.
126.

Tetsumoto A, Imai H, Otsuka K, Matsumiya W, Miki A, Nakamura M. Clinical factors

contributing to postoperative aqueous flare intensity after 27-gauge pars plana vitrectomy
for the primary rhegmatogenous retinal detachment. Jpn J Ophthalmol. 2019 63(4):317-321.
127.

Katsuyama A, Kusuhara S, Nishisho R, Matsumiya W, Azumi A, Nakamura M. Long-

term efficacy and safety of infliximab and cyclosporine combination therapy for refractory
uveoretinitis in Behçet's disease. Clin Ophthalmol. 2019;13:521-527.
128.

Mori S, Kurimoto T, Kanamori A, Sakamoto M, Ueda K, Yamada-Nakanishi Y,

Nakamura M. Discordance of Disc-Fovea Raphe Angles Determined by Optical Coherence
Tomography and MP-3 Microperimetry in Eyes With a Glaucomatous Hemifield Defect.
Invest Ophthalmol Vis Sci. 2019;60(5):1403-1411.
129.

Nakai S, Matsumiya W, Otsuka K, Miki A, Nakamura M, Honda S. The 24-monthoutcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal
choroidal vasculopathy. Jpn J Ophthalmol. 2019;63(1):100-108.
130.

Nakai S, Matsumiya W, Miki A, Honda S, Nakamura M. Association of an age-related

maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal

aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Jpn J Ophthalmol. 2019 63(5):389-395.
131.

Miki A, Yamada Y, Nakamura M. The Size of the Foveal Avascular Zone Is Associatedwith Foveal Thickness and Structure in Premature Children. J Ophthalmol. 2019 Jul
2;2019:8340729.
132.

Hayashida M, Miki A, Imai H, Otsuka K, Azumi A, Nakamura M. Impact of Early

Vitrectomy

for

Dense

Vitreous

Hemorrhage

ofUnknown

Etiology.

Ophthalmologica.2019;242(4):234-238.
133.

Mori S, Kurimoto T, Maeda H, Nakamura M.Dimethyl Fumarate Promotes the Survivalof Retinal Ganglion Cells after Optic Nerve Injury, Possibly through the Nrf2/HO-1 Pathway.
Int J Mol Sci 2020; 22(1): 297
134.

Imai H, Tetsumoto A, Yamada H, Nakamura M. Impact of different manufacturers andgauge sizes on the performance of backflush needle. Sci Rep 2020; 10(1): 21452
135.

Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, Nakamura

M.Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy inpatients with central serous chorioretinopathy with good baseline visual acuity. PLoS One
2020; 15(10): e0240557
136.

Mori S, Kurimoto T, Miki A, Maeda H, Kusuhara S, Nakamura M. Aqp9 Gene Deletion

Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by Optic Nerve
Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron Lactate Shuttle in Concert
with Monocarboxylate Transporters To Support RGC Function and Survival. Mol Neurobiol
2020; 57(11): 4530-4548
137.

Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, Honda S,Nakamura

M. Genetic factors associated with treatment response to reduced-fluence photodynamic
therapy for chronic central serous chorioretinopathy. Mol Vis 2020; 26: 505-509
138.

Kurimoto T, Ueda K, Mori S, Kamada S, Sakamoto M, Yamada-Nakanishi Y,Matsumiya

W, Nakamura M. A Single-Arm, Prospective, Exploratory Study to Preliminarily Test
Effectiveness and Safety of Skin Electrical Stimulation for Leber Hereditary Optic
Neuropathy. J Clin Med 2020; 9(5): 1359
139.

Mori S, Murai Y, Ueda K, Sakamoto M, Kurimoto T, Yamada-Nakanishi Y, Nakamura

M. A comparison of the 1-year surgical outcomes of ab externo trabeculotomy andmicrohook ab interno trabeculotomy using propensity score analysis. BMJ Open Ophthalmol
2020; 5(1): e000446
140.

Katsuyama A, Kusuhara S, Asahara SI, Nakai SI, Mori S, Matsumiya W, Miki A,

Kurimoto T, Imai H, Kido Y, Ogawa W, Nakamura M. En face slab optical coherence
tomography imaging successfully monitors progressive degenerative changes in the
innermost layer of the diabetic retina. BMJ Open Diabetes Res Care 2020; 8(1): e001120
141.

Ueda K, Miki A, Nakai S, Yanagisawa S, Nomura K, Nakamura M. Prediction of severe

retinopathy of prematurity using the weight gain, insulin-like growth factor 1, and neonatal
retinopathy of prematurity algorithm in a Japanese population of preterm infants. Jpn J
Ophthalmol 2020; 64(2): 223-227

142.

Imai H, Otsuka K, Tetsumoto A, Miki A, Nakamura M. EFFECTIVENESS OF EN

BLOC REMOVAL OF FIBRINOGEN-RICH COMPONENT OF CYSTOID LESION FOR
THE TREATMENT OF CYSTOID MACULAR EDEMA. Retina 2020; 40(1): 154-159
143.

Tetsumoto A, Imai H, Hayashida M, Otsuka K, Matsumiya W, Miki A, Nakamura M.

The comparison of the surgical outcome of 27-gauge pars plana vitrectomy for primaryrhegmatogenous retinal detachment between air and SF6 gas tamponade. Eye (Lond) 2020;34(2): 299-306
144.

Hayashida M, Miki A, Honda S, Nakamura M. Comparison between the outcomesoffluorescein angiography-guided and indocyanine green angiography-guided half-time
photodynamic therapy for central serous chorioretinopathy. Photodiagnosis Photodyn Ther
2020; Sep;31:101955
145.

Nishisho R, Kusuhara S, Sotani N, Kim KW, Katsuyama-Yoshikawa A, Matsumiya W,

Akashi K, Morinobu A, Nakamura M. Changes in choroidal imaging parameters following
adalimumab therapy for refractory noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol
2021; 259(5): 1273-80.
146.

Imai H, Tetsumoto A, Yamada H, Hayashida M, Otsuka K, Miki A, Kusuhara

S,Nakamura M. The long-term effect of cystotomy with or without the fibrinogen clot
removal for the refractory cystoid macular edema secondary to diabetic retinopathy. Retina
2021; 41(4):844-851
147.

Imai H, Tetsumoto A, Inoue S, Takano F, Yamada H, Hayashida M, Otsuka K, Miki A,

Kusuhara S, Nakamura M. Intraoperative Three-Dimensional Fluorescein AngiographyGuided Pars Plana Vitrectomy for the Treatment of Proliferative Diabetic Retinopathy: The
Maximized Utility of the Digital Assisted Vitrectomy. Retina 2020; Online ahead of print
148.

Sakai D, Takagi S, Hirami Y, Nakamura M, Kurimoto Y. Correlation between tangential

distortion of the outer retinal layer and metamorphopsia in patients with epiretinal membrane.
Graefes Arch Clin Exp Ophthalmol 2020; Online ahead of print

II. Case Reports
1. Nakamura M, Tanigawa M, Yamamoto M. A case of Leber's hereditary optic neuropathy with amitochondrial DNA mutation at nucleotide position 3460. Jpn J Ophthalmol 1994, 38: 267-271.
(IF=0.924, CI=6)
2. Nakamachi Y, Nakamura M, Fujii S, Yamamoto M, Okubo K. Oguchi disease with sectoral
retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin gene. Am J
Ophthalmol 1998, 125: 249-251. (IF=4.223, CI=22)
3. Nakamura M, Tanabe M, Yamada Y, Azumi A. Zoster sine herpete with bilateral ocular
involvement. Am J Ophthalmol 2000, 129:809-810. (IF=4.223, CI=8)
4. Nakamura M, Kanamori A, Seya R, Maeda H, Negi A. A case of occult macular dystrophy
accompanying normal-tension glaucoma. Am J Ophthalmol 2003, 135:715-717. (IF=4.223,
CI=4)
5. Kanamori A, Nakamura M, Matsui N, Tomimori H, Tanase M, Seya R, Maeda H, Negi A.
Goniosynechialysis with lens aspiration and posterior chamber intraocular lens implantation forglaucoma in spherophakia. J Cataract Refract Surg 2004, 30: 513-516. (IF=2.2264, CI=4)
6. Nagai A, Kanamori A, Kusuhara S, Nakamura M, Negi A. Unilateral manifestation of Leber’s
hereditary optic neuropathy after blunt ocular trauma. Jpn J Ophthalmol 2005, 49: 65-67.
(IF=0.924, CI=1)
7. Nakamura M, Kanamori A, Kusuhara S, Ishibashi K, Negi A. Alternate total ophthalmoplegia
and optic neuropathy associated with ulcerative colitis. Eye 2005, 19: 235-237. (IF=1.851,
CI=0)
8. Tatsumi Y, Kanamori A, Kusuhara A, Nakanishi Y, Kusuhara S, Nakamura M (corresponding
author). Retinal nerve fiber layer thickness in optic tract syndrome. Jpn J Ophthalmol 2005, 49:
294-296. (IF=0.924, CI=7)
9. Kakutani Y, Nakamura M (corresponding author), Nagai-Kusuhara A, Kanamori A, Negi A.
Marked cup reversal presumably associated with scleral biomechanics in a case of adultglaucoma. Arch Ophthalmol 2010, 128: 139-141. (IF=3.711, CI=3)
10. Nakano S, Kanamori A, Nakamura M, Mizukawa K, Negi A. Paraneoplastic optic neuropathy
associated with cerebellar choroid meningioma. Eye 2013, Epub ahead pf print (IF=1.851,
CI=0)
11. Tagami M, Honda S, Morioka I, Iijima K, Yamada H, Nakamura M. An unusual case ofcongenital cytomegalovirus infection-related retinopathy. BMC Ophthalmol. 2016;16:81
12. Nakano Y, Miki A, Honda S, Nakamura M. Polypoidal Choroidal Vasculopathy Associatedwith Optic Disc Coloboma. Case Rep Ophthalmol. 2018;9(1):92-95.
13. Obata S, Miki A, Imai H, Nakamura M. Bilateral corneal denting after surgery under generalanesthesia: A case report. Am J Ophthalmol Case Rep. 2018;10:290-292.
14. Miki A, Fujihara M, Yoshida A, Nakamura M, Azumi A. A case of bilateral vasculitis
associated with pineal germinoma. Am J Ophthalmol Case Rep. 2018;11:142-145.
15. Mori S, Kurimoto T, Ueda K, Enomoto H, Sakamoto M, Keshi Y, Yamada Y, Nakamura M.
Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with NonSmall Cell Lung Carcinoma. Case Rep Ophthalmol. 2018;9(2):348-356.
16. Sakamoto M, Kurimoto T, Mori S, Ueda K, Keshi Y, Yamada Y, Azumi A, Shimono T,
Nakamura M. Vasculitis with superior ophthalmic vein thrombosis compatible with neuroneutrophilic disease. Am J Ophthalmol Case Rep. 2018;12:39-44.
17. Mori S, Kurimoto T, Kawara K, Ueda K, Sakamoto M, Keshi Y, Yamada-Nakanishi Y,
Tachibana H, Nakamura M. The Difficulty of Diagnosing Invasive Aspergillosis Initially
Manifesting as Optic Neuropathy. Case Rep Ophthalmol. 2019;10(1):11-18.
18. Yamada H, Kurimoto T, Mori S, Sakamoto M, Ueda K, Yamada-Nakanishi Y, Uozumi Y,
Shose H, Taniguchi M, Toyoda M, Minami H, Nakamura M. A Case of Multi-System
Langerhans Cell Histiocytosis with Local Invasion of the Orbital Apex. Case Rep
Ophthalmol. 2019;10(3):319-326.
19. Katsuyama A, Kusuhara S, Awano H, Nagase H, Matsumiya W, Nakamura M. A case ofprobable Vogt-Koyanagi-Harada disease in a 3-year-old girl. BMC Ophthalmol. 201913;19(1):179.
20. Kimura M, Kusuhara S, Tagami M, Nakamura M. Impaired Retinal Circulation during

Axitinib Treatment for Metastatic Renal Cell Carcinoma. Case Rep Ophthalmol.
2019;10(1):5-10.
21. Inoue S, Imai H, Tetsumoto A, Otsuka K, Nakamura M. A Rare Case of Lens-Induced
Uveitis with Proliferative Vitreoretinopathy and Massive Encapsulation of Fallen Nuclear
Material Case Rep Ophthalmol 2020; 11(2): 436-441
22. Mori S, Kurimoto T, Ueda K, Sakamoto M, Chihara N, Satake W, Yamada-Nakanishi Y,
Nakamura M. A case of neurosarcoidosis presenting with multiple cranial neuropathies. Am J
Ophthalmol Case Rep 2020; 19: 100796
23. Sakai D, Matsumiya W, Kusuhara S, Nakamura M. The choroidal structure changes in a casewith hypertensive choroidopathy.Am J Ophthalmol Case Rep 2020; 18: 100710
24. Tetsumoto A, Imai H, Miki A, Nakamura M. A CASE OF RETINAL METASTASIS OFLARYNGEAL SQUAMOUS CELL CARCINOMA WITH HISTOPATHOLOGICCONFIRMATION BY VITRECTOMY-ASSISTED EN BLOCK EXTRACTION. Retin
Cases Brief Rep 2020; 14(2): 127-130
25. Maki H, Imai H, Yamada H, Tetsumoto A, Hayashida M, Otsuka K, Miki A, Nakamura M.
The long-term effect of cystotomy with fibrinogen clot removal for a cystoid macular edema
secondary to idiopathic macular telangiectasia type 1: a case report. Retin Cases Brief Rep
2020; Publish ahead of print

III. Review
1. Fujiwara Y, Nakamura A, Yokoo S, Nakamura M. Senescence of normal human and progeroid
cells as a potential model of aging. In, New horizons in aging science. Eds., Orimo H, Fukuchi Y,
Kuramoto K, Iriki M. The University of Tokyo Press, Tokyo, 1992, 87-88.
2. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Nakamura M. New insights into thepathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabet Technol& Ther 2000, 2: 601-608. (IF=1.931, CI=25).
3. Barber AJ, Nakamura M, Penn State Retina Research Group. Apoptosis and neurodegeneration indiabetes: Lessons from the retina. In, Diabetic renal-retinal syndrome. Eds., Friedman EA,
L’Esperance FA Jr. Kluwer Academic Publishers, Netherlands, 2002, 35-45.
4. Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic
neuropathy. Ophthalmologica 2005, 219: 1-10 (IF=1.424, CI=29).
5. Kusuhara S, Nakamura M. Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma:
Safety, Efficacy, and Patient Selection. Clin Ophthalmol 2020; 14: 1229-1236